Medical/Pharmaceuticals

AGC Biologics' $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

SEATTLE, Nov. 12, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at theirSeattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of...

2019-11-12 20:00 403

ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders

BERLIN and TORONTO, Nov. 11, 2019 /PRNewswire/ -- ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, andCyclica Inc., a leading biotechnology company that leverages artificial intelligence and computational biophysics to streamline the drug discovery proce...

2019-11-11 21:45 449

TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092

SUZHOU, China, Nov. 11, 2019 /PRNewswire/ -- TenNor Therapeutics reported positive top-line results for TNP-2092 powder for injection from a phase II clinical trial conducted inthe United States. TNP-2092 is currently under clinical development for the treatment ofprosthetic joint infections and ...

2019-11-11 21:00 319

Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director

HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independen...

2019-11-11 19:30 3054

Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting

NATIONAL HARBOR, Md., Nov. 11, 2019 /PRNewswire/ -- Akeso Biopharma ("Akeso") presented results of phase 1 study of its first-in-class bispecific drug candidate  AK104, in patients with advanced solid tumors in 2019 Society for Immunotherapy of Cancer ("SITC"). AK104 is a novel, tetrameric bispec...

2019-11-11 17:35 238

Taiwan Healthcare Pavilion Promotes Their Smart Medical Industry in Phillipines

DAVAO, Phillipines, Nov. 11, 2019 /PRNewswire/ -- The event took place on 8th – 9th November 2019, Davao, Phillipines. Taiwan Healthcare Pavilion (Stall number 200) stands apart at the Taiwan Expo 2019, SMX Convention center, Davao,Philippines. The Taiwan Healthcare Pavilion has assembled 8 hig...

2019-11-11 15:31 360

qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features

SINGAPORE, Nov. 11, 2019 /PRNewswire/ -- qFIBS, a novel automated algorithm developed byHistoIndex , has been shown to accurately distinguish different grades and stages of histological NASH features with a continuous measurement approach. This was...

2019-11-11 13:28 362

Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore

SINGAPORE, Nov. 11, 2019 /PRNewswire/ -- Stone Capital and Biosyngen have partnered to establish a Biopharmaceutical Investment Fund inSingapore, the signing ceremony was held in Ascendas One Hub of Sino-Singapore Guangzhou Knowledge City. The key investment targets of the biopharmaceutical fund...

2019-11-11 10:00 295

Akeso, Inc. Completes Series-D Private Financing for US$150 Million

ZHONGSHAN, China, Nov. 9, 2019 /PRNewswire/ -- Akeso, Inc. (hereinafter referred to as "Akeso") announced the completion of its Series-D private financing for nearlyUS$150 million, which was co-led in investment by Loyal Valley Capital ("LVC") and Sino Biopharmaceutical Co. Ltd. ("Sino Biopharm")...

2019-11-09 00:43 1349

Ortoma Initiates Expansion With Module for Spine Surgery

STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma Treatment Solution (OTS) with a module also for spine surgery. -The conclusion after a number of perfor...

2019-11-08 21:40 5390

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

MADISON, Wisconsin, Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed itspreviously announced combination with Genomic Health, Inc. (NASDAQ: GHDX). "Today marks a pivotal step toward building the world's leading advanced cancer diagnostics co...

2019-11-08 21:24 5671

Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial

Not intended for US, Canada and UK-based media  DARMSTADT, Germany, and NEW YORK, Nov. 8, 2019 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluating avelumab as first-line maintenance therapy following induction ch...

2019-11-08 21:00 4727

SINOCHEM PHARMACEUTICAL Participated in CPhI Worldwide Europe

FRANKFURT, Germany, Nov. 8, 2019 /PRNewswire/ -- From November 5 to 7, 2019, CPhI Worldwide Europe was held in the Exhibition CentreFrankfurt, Germany. Dong Jianhua, executive director of Sinochem Pharmaceutical Co., Ltd., led a delegation to attend the exhibition. Sinochem Pharmaceutical has be...

2019-11-08 17:36 293

Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes

BAD HOMBURG, Germany, Nov. 8, 2019 /PRNewswire/ -- A new systematic literature review and meta-analysis[1] confirms and extends previous results that omega-3 (ω-3) fatty-acid enriched parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients. Including a tot...

2019-11-08 11:00 620

Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent

Largest Set of MIGS Data Ever Produced in Australia Includes Over 900 Eyes with 200+ Stand-Alone Glaucoma Procedures IRVINE, California, Nov. 8, 2019 /PRNewswire/ -- Ivantis today announced long term results of the Australian cohort of the Global SPECTRUM registry. SPECTRUM is a post market pati...

2019-11-08 03:00 548

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost

PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...

2019-11-07 21:02 573

Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost

PUNE, India, Nov. 7, 2019 /PRNewswire/ -- Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, India. This first-of-its-kind facility was built in half the time as compared to the conventional biologics manufacturing plants. The s...

2019-11-07 20:24 367

TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma

NANJING, China, Nov. 7, 2019 /PRNewswire/ -- TransThera Biosciences Co. Ltd, announced today that company received Orphan Drug Designation from US Food and Drug Administration (FDA) for TT-00420, a clinical stage investigational drug, for the treatment of cholangiocarcinoma. Dr. Frank Wu, Founde...

2019-11-07 20:08 295

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...

2019-11-07 19:04 5371

Bactiguard Holding AB (publ): Interim Report for Q3 2019

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...

2019-11-07 15:23 5252
12345 ... 356